Shanghai Junshi Biosciences Co Ltd (1877)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 17.20 |
|---|---|
| 52-week range | 15.25 – 30.80 |
| Return, 1 month / 3 months | −0.6% / −10.5% |
| Return, 1 year / 3 years | −41.9% / −6.1% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 54.0% |
| Worst drawdown (1 year) | -46.9% |
| Average daily value traded | 43.35M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shanghai Junshi Biosciences is a biopharmaceutical company based in Shanghai that discovers, develops and commercialises biologic medicines, chiefly monoclonal antibodies for cancer and inflammatory disease. Its antibody therapies are used by hospitals and clinicians treating patients with cancers such as melanoma, nasopharyngeal carcinoma and lung cancer, and it also pursues antiviral and autoimmune treatments. The company carries out research and clinical development in China and works with partners abroad to bring its medicines to wider markets.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 1877, and the price on this page is in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shanghai Junshi Biosciences Co Ltd (1877) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 17.20 on 21 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 1,415 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 41.9% and over the last three months it fell 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.4% | ||
| From 52-week high | -40.6% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.5% | ||
| 6-month return | -39.9% | ||
| 12-month return, skipping the last month | -41.5% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 54.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.9% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 43.35M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −0.6% |
| 3 months | −10.5% |
| 6 months | −39.9% |
| 1 year | −41.9% |
| 3 years | −6.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 18.11 / 20.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.